APO RESEARCH · REPORT
Clotrimazole
Clotrimazole is a white powdered pharmaceutical used for treatment of dermatological and gynaecological fungal infections. Clotrimazole was synthesised in 1969 firstly and its chemical name is 1-[(2-chloro-phenyl)(diphenyl)methyl]-1H-imidazole). Its molecular formula is C22H17ClN2 and the molecular weight is 344.8 g/mol.Clotrimazole is an inhibitor of ergosterol biosynthesis. It has many ecotoxicological properties in common with a range of fungicides used in agriculture. Clotrimazole is a broad-spectrum antimycotic agent effective pathogenic dermophytes, yeasts, Candida, Trichophyton, etc.
Product & engineering
Understand the product.
Clotrimazole is a white powdered pharmaceutical used for treatment of dermatological and gynaecological fungal infections. Clotrimazole was synthesised in 1969 firstly and its chemical name is 1-[(2-chloro-phenyl)(diphenyl)methyl]-1H-imidazole). Its molecular formula is C22H17ClN2 and the molecular weight is 344.8 g/mol.Clotrimazole is an inhibitor of ergosterol biosynthesis. It has many ecotoxicological properties in common with a range of fungicides used in agriculture. Clotrimazole is a broad-spectrum antimycotic agent effective pathogenic dermophytes, yeasts, Candida, Trichophyton, etc.
Selected research
Industry Research
Clotrimazole Industry Research Report 2026
Market perspective
Clotrimazole is a white powdered pharmaceutical used for treatment of dermatological and gynaecological fungal infections. Clotrimazole was synthesised in 1969 firstly and its chemical name is 1-[(2-chloro-phenyl)(diphenyl)methyl]-1H-imidazole). Its molecular formula is C22H17ClN2 and the molecular weight is 344.8 g/mol.Clotrimazole is an inhibitor of ergosterol biosynthesis. It has many ecotoxicological properties in common with a range of fungicides used in agriculture. Clotrimazole is a broad-spectrum antimycotic agent effective pathogenic dermophytes, yeasts, Candida, Trichophyton, etc.
Global Clotrimazole key players include Guangzhou Hanpu, Jiangsu Yunyang, Bayer, Erregierre, Wuhan DKY, etc. Global top five manufacturers hold a share over 65%.
China is the largest market, with a share over 60%, followed by EU and India, both have a share over 30%.
Read the full market overview
In terms of product, Cream is the largest segment, with a share over 40%. And in terms of application, the largest application is Vaginitis, followed by Tinea of Feed and Hands, Tinea Corporis, etc.
Report Scope
This report quantifies the global Clotrimazole market in terms of revenue (US$ million) and, where applicable, sales volume (Ton), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Ton) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Clotrimazole Market by Company
Bayer
Erregierre
F.I.S.
Amoli Organics
CordenPharma
Ciron Group
Halcyon Labs
INFA Group
Manus Aktteva
Guangzhou Hanpu
Jiangsu Yunyang
Wuhan DKY
Hubei Aoxiang
Jintan Zhongxing
Clotrimazole Segment by Type
Suppository
Tablet
Cream
Others
Clotrimazole Segment by Application
Vaginitis
Otomycosis
Paronychia
Tinea of Feed and Hands
Tinea Corporis
Others
Clotrimazole Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Clotrimazole market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Clotrimazole and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Clotrimazole.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Clotrimazole manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Clotrimazole by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Clotrimazole in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Suppository
- Tablet
- Cream
- Others
Applications
- Vaginitis
- Otomycosis
- Paronychia
- Tinea of Feed and Hands
- Tinea Corporis
- Others
Companies covered
- Bayer
- Erregierre
- F.I.S.
- Amoli Organics
- CordenPharma
- Ciron Group
- Halcyon Labs
- INFA Group
- Manus Aktteva
- Guangzhou Hanpu
- Jiangsu Yunyang
- Wuhan DKY
- Hubei Aoxiang
- Jintan Zhongxing
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Clotrimazole Market Size (2021-2032)
- 2.2.2 Global Clotrimazole Sales (2021-2032)
- 2.2.3 Global Clotrimazole Market Average Price (2021-2032)
- 2.3 Clotrimazole by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Suppository
- 2.3.3 Tablet
- 2.3.4 Cream
- 2.3.5 Others
- 2.4 Clotrimazole by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Vaginitis
- 2.4.3 Otomycosis
- 2.4.4 Paronychia
- 2.4.5 Tinea of Feed and Hands
- 2.4.6 Tinea Corporis
- 2.4.7 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Clotrimazole Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Clotrimazole Sales (Ton) of Manufacturers (2021-2026)
- 3.3 Global Clotrimazole Revenue of Manufacturers (2021-2026)
- 3.4 Global Clotrimazole Average Price by Manufacturers (2021-2026)
- 3.5 Global Clotrimazole Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Clotrimazole, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Clotrimazole, Product Type & Application
- 3.8 Global Manufacturers of Clotrimazole, Established Date
- 3.9 Global Clotrimazole Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Bayer
- 4.1.1 Bayer Company Information
- 4.1.2 Bayer Business Overview
- 4.1.3 Bayer Clotrimazole Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Bayer Clotrimazole Product Portfolio
- 4.1.5 Bayer Recent Developments
- 4.2 Erregierre
- 4.2.1 Erregierre Company Information
- 4.2.2 Erregierre Business Overview
- 4.2.3 Erregierre Clotrimazole Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Erregierre Clotrimazole Product Portfolio
- 4.2.5 Erregierre Recent Developments
- 4.3 F.I.S.
- 4.3.1 F.I.S. Company Information
- 4.3.2 F.I.S. Business Overview
- 4.3.3 F.I.S. Clotrimazole Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 F.I.S. Clotrimazole Product Portfolio
- 4.3.5 F.I.S. Recent Developments
- 4.4 Amoli Organics
- 4.4.1 Amoli Organics Company Information
- 4.4.2 Amoli Organics Business Overview
- 4.4.3 Amoli Organics Clotrimazole Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Amoli Organics Clotrimazole Product Portfolio
- 4.4.5 Amoli Organics Recent Developments
- 4.5 CordenPharma
- 4.5.1 CordenPharma Company Information
- 4.5.2 CordenPharma Business Overview
- 4.5.3 CordenPharma Clotrimazole Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 CordenPharma Clotrimazole Product Portfolio
- 4.5.5 CordenPharma Recent Developments
- 4.6 Ciron Group
- 4.6.1 Ciron Group Company Information
- 4.6.2 Ciron Group Business Overview
- 4.6.3 Ciron Group Clotrimazole Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Ciron Group Clotrimazole Product Portfolio
- 4.6.5 Ciron Group Recent Developments
- 4.7 Halcyon Labs
- 4.7.1 Halcyon Labs Company Information
- 4.7.2 Halcyon Labs Business Overview
- 4.7.3 Halcyon Labs Clotrimazole Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Halcyon Labs Clotrimazole Product Portfolio
- 4.7.5 Halcyon Labs Recent Developments
- 4.8 INFA Group
- 4.8.1 INFA Group Company Information
- 4.8.2 INFA Group Business Overview
- 4.8.3 INFA Group Clotrimazole Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 INFA Group Clotrimazole Product Portfolio
- 4.8.5 INFA Group Recent Developments
- 4.9 Manus Aktteva
- 4.9.1 Manus Aktteva Company Information
- 4.9.2 Manus Aktteva Business Overview
- 4.9.3 Manus Aktteva Clotrimazole Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Manus Aktteva Clotrimazole Product Portfolio
- 4.9.5 Manus Aktteva Recent Developments
- 4.10 Guangzhou Hanpu
- 4.10.1 Guangzhou Hanpu Company Information
- 4.10.2 Guangzhou Hanpu Business Overview
- 4.10.3 Guangzhou Hanpu Clotrimazole Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Guangzhou Hanpu Clotrimazole Product Portfolio
- 4.10.5 Guangzhou Hanpu Recent Developments
- 4.11 Jiangsu Yunyang
- 4.11.1 Jiangsu Yunyang Company Information
- 4.11.2 Jiangsu Yunyang Business Overview
- 4.11.3 Jiangsu Yunyang Clotrimazole Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Jiangsu Yunyang Clotrimazole Product Portfolio
- 4.11.5 Jiangsu Yunyang Recent Developments
- 4.12 Wuhan DKY
- 4.12.1 Wuhan DKY Company Information
- 4.12.2 Wuhan DKY Business Overview
- 4.12.3 Wuhan DKY Clotrimazole Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Wuhan DKY Clotrimazole Product Portfolio
- 4.12.5 Wuhan DKY Recent Developments
- 4.13 Hubei Aoxiang
- 4.13.1 Hubei Aoxiang Company Information
- 4.13.2 Hubei Aoxiang Business Overview
- 4.13.3 Hubei Aoxiang Clotrimazole Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Hubei Aoxiang Clotrimazole Product Portfolio
- 4.13.5 Hubei Aoxiang Recent Developments
- 4.14 Jintan Zhongxing
- 4.14.1 Jintan Zhongxing Company Information
- 4.14.2 Jintan Zhongxing Business Overview
- 4.14.3 Jintan Zhongxing Clotrimazole Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Jintan Zhongxing Clotrimazole Product Portfolio
- 4.14.5 Jintan Zhongxing Recent Developments
5 Global Clotrimazole Market Scenario by Region
- 5.1 Global Clotrimazole Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Clotrimazole Sales by Region: 2021-2032
- 5.2.1 Global Clotrimazole Sales by Region: 2021-2026
- 5.2.2 Global Clotrimazole Sales by Region: 2027-2032
- 5.3 Global Clotrimazole Revenue by Region: 2021-2032
- 5.3.1 Global Clotrimazole Revenue by Region: 2021-2026
- 5.3.2 Global Clotrimazole Revenue by Region: 2027-2032
- 5.4 North America Clotrimazole Market Facts & Figures by Country
- 5.4.1 North America Clotrimazole Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Clotrimazole Sales by Country (2021-2032)
- 5.4.3 North America Clotrimazole Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Clotrimazole Market Facts & Figures by Country
- 5.5.1 Europe Clotrimazole Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Clotrimazole Sales by Country (2021-2032)
- 5.5.3 Europe Clotrimazole Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Clotrimazole Market Facts & Figures by Country
- 5.6.1 Asia Pacific Clotrimazole Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Clotrimazole Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Clotrimazole Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Clotrimazole Market Facts & Figures by Country
- 5.7.1 South America Clotrimazole Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Clotrimazole Sales by Country (2021-2032)
- 5.7.3 South America Clotrimazole Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Clotrimazole Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Clotrimazole Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Clotrimazole Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Clotrimazole Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Clotrimazole Sales by Type (2021-2032)
- 6.1.1 Global Clotrimazole Sales by Type (2021-2032) & (Ton)
- 6.1.2 Global Clotrimazole Sales Market Share by Type (2021-2032)
- 6.2 Global Clotrimazole Revenue by Type (2021-2032)
- 6.2.1 Global Clotrimazole Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Clotrimazole Revenue Market Share by Type (2021-2032)
- 6.3 Global Clotrimazole Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Clotrimazole Sales by Application (2021-2032)
- 7.1.1 Global Clotrimazole Sales by Application (2021-2032) & (Ton)
- 7.1.2 Global Clotrimazole Sales Market Share by Application (2021-2032)
- 7.2 Global Clotrimazole Revenue by Application (2021-2032)
- 7.2.1 Global Clotrimazole Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Clotrimazole Revenue Market Share by Application (2021-2032)
- 7.3 Global Clotrimazole Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Clotrimazole Value Chain Analysis
- 8.1.1 Clotrimazole Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Clotrimazole Production Mode & Process
- 8.2 Clotrimazole Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Clotrimazole Distributors
- 8.2.3 Clotrimazole Customers
9 Global Clotrimazole Analyzing Market Dynamics
- 9.1 Clotrimazole Industry Trends
- 9.2 Clotrimazole Industry Drivers
- 9.3 Clotrimazole Industry Opportunities and Challenges
- 9.4 Clotrimazole Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst